The global oncologic disorders testing sector is exhibiting significant expansion, propelled by a rising prevalence of lymphoma and other related illnesses. Researchers estimate the current market size to be substantial, with projections indicating a steady compound annual increase rate (CAGR) over the projected period. Key factors shaping the aren